Using APOE as a Key in Alzheimer s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk Benefit Conundrum

Using APOE as a Key in Alzheimer s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk Benefit Conundrum

Using APOE as a Key: Unlocking the Risk-Benefit Conundrum of Amyloid-Targeting Therapy in Alzheimer s Disease

  • Provider:PVI, PeerView Institute for Medical Education
  • Activity Link: https://www.peerview.com/WZX
  • Start Date: 2024-10-17 05:00:00
  • End Date: 2024-10-17 05:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
    ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM)
  • Commercial Support: Source: Lilly (Any division) - Amount: 126794.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Geriatric Medicine
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.